{'fraction_non_alphanumeric': 0.01607717041800643, 'fraction_numerical': 0.007502679528403001, 'mean_word_length': 5.3108108108108105, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Evaluation of EM absorption loss for continuous monitoring of breast cancer

Continuous monitoring of breast cancer is a vital step in the treatment plan of a breast cancer survivor who has an 11-20% risk of recurrence and a 3x-4x chance of developing breast cancer in a different location within the breast. This study proposes electromagnetic (EM) absorption loss measurements as a cost-effective method which has the potential to replace the rudimentary and inaccurate breast self-examination and complement the traditional X-ray mammography exams, which are cost-prohibitive and carry radiation exposure risk. A breast cancer survivor can continuously monitor the health of her breast by periodically comparing absorption loss measurements to a reference absorption loss measurement taken after a lumpectomy. Results show successful detection of tumors at different locations within the breast with just a 3-element phased array.